Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 S Garazzino, C Montagnani, D Donà, A Meini, E Felici, G Vergine, ... Eurosurveillance 25 (18), 2000600, 2020 | 360 | 2020 |
The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for … A Versporten, J Bielicki, N Drapier, M Sharland, H Goossens, ... Journal of Antimicrobial Chemotherapy 71 (4), 1106-1117, 2016 | 322 | 2016 |
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review C Minotti, F Tirelli, E Barbieri, C Giaquinto, D Dona Journal of Infection 81 (1), e61-e66, 2020 | 249 | 2020 |
Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review D Donà, E Barbieri, M Daverio, R Lundin, C Giaquinto, T Zaoutis, ... Antimicrobial Resistance & Infection Control 9, 1-12, 2020 | 136 | 2020 |
Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project M De Luca, D Donà, C Montagnani, A Lo Vecchio, M Romanengo, ... PLoS One 11 (5), e0154662, 2016 | 78 | 2016 |
Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian multicenter study S Garazzino, A Lo Vecchio, L Pierantoni, FI Calò Carducci, F Marchetti, ... Frontiers in pediatrics 9, 649358, 2021 | 72 | 2021 |
Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious Disease E Venturini, C Montagnani, S Garazzino, D Donà, L Pierantoni, ... Italian journal of pediatrics 46, 1-11, 2020 | 71 | 2020 |
Epidemiology of frequently occurring skin diseases in Italian children from 2006 to 2012: a retrospective, population‐based study A Cantarutti, D Donà, F Visentin, E Borgia, A Scamarcia, L Cantarutti, ... Pediatric dermatology 32 (5), 668-678, 2015 | 62 | 2015 |
Long-term immune response to SARS-CoV-2 infection among children and adults after mild infection C Di Chiara, A Cantarutti, P Costenaro, D Donà, F Bonfante, C Cosma, ... JAMA network open 5 (7), e2221616-e2221616, 2022 | 60 | 2022 |
Fecal-oral transmission of SARS-CoV-2 in children: is it time to change our approach? D Donà, C Minotti, P Costenaro, L Da Dalt, C Giaquinto The Pediatric Infectious Disease Journal 39 (7), e133-e134, 2020 | 57 | 2020 |
Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact D Donà, C Di Chiara, M Sharland J Hosp Infect 106 (1), 198-199, 2020 | 57 | 2020 |
Mild SARS-CoV-2 infections and neutralizing antibody titers F Bonfante, P Costenaro, A Cantarutti, C Di Chiara, A Bortolami, ... Pediatrics 148 (3), 2021 | 54 | 2021 |
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies N Cotugno, A Ruggiero, F Bonfante, MR Petrara, S Zicari, GR Pascucci, ... Cell reports 34 (11), 2021 | 50 | 2021 |
SARS‐CoV‐2 infection in people living with HIV: a systematic review P Costenaro, C Minotti, E Barbieri, C Giaquinto, D Dona Reviews in medical virology 31 (1), 1-12, 2021 | 50 | 2021 |
The use of handheld near-infrared device (Infrascanner) for detecting intracranial haemorrhages in children with minor head injury S Bressan, M Daverio, F Martinolli, D Dona’, F Mario, IP Steiner, L Da Dalt Child's nervous system 30, 477-484, 2014 | 50 | 2014 |
Pediatric transplantation in Europe during the COVID‐19 pandemic: early impact on activity and healthcare D Doná, J Torres Canizales, E Benetti, M Cananzi, F De Corti, E Calore, ... Clinical transplantation 34 (10), e14063, 2020 | 47 | 2020 |
The use of polymyxins to treat carbapenem resistant infections in neonates and children R Thomas, S Velaphi, S Ellis, AS Walker, JF Standing, P Heath, ... Expert opinion on pharmacotherapy 20 (4), 415-422, 2019 | 46 | 2019 |
Risk factors for complications in children with Staphylococcus aureus bacteremia RF Hamdy, D Dona, MB Jacobs, JS Gerber The Journal of Pediatrics 208, 214-220. e2, 2019 | 44 | 2019 |
Factors associated with severe gastrointestinal diagnoses in children with SARS-CoV-2 infection or multisystem inflammatory syndrome AL Vecchio, S Garazzino, A Smarrazzo, E Venturini, M Poeta, P Berlese, ... JAMA network open 4 (12), e2139974-e2139974, 2021 | 42 | 2021 |
Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia D Donà, S Zingarella, A Gastaldi, R Lundin, G Perilongo, AC Frigo, ... PLoS One 13 (2), e0193581, 2018 | 40 | 2018 |